Chandra Adams
Senior VP, General Counsel & SecretaryMs. Chandra Adams, J.D. served as Vice President, Legal & Intellectual Property at Surface Oncology Inc. from February 2021 to October 2022 and served as its Deputy General Counsel and Corporate Secretary at Surface Oncology Inc. since October 2022 until September 08, 2023. She is General Counsel of Climb Bio, Inc. from May 2025 and serves as its Secretary and serves as Senior Vice President from July 2026 and served as its Vice President until July 2026. In addition to her experience as an intellectual property attorney, she also brings expertise in regulatory and general corporate matters to the role. Prior to joining Surface, she served in legal positions of increasing seniority at Bioverativ Inc. (acquired by Sanofi in 2018), Vertex Pharmaceuticals, Inc. and Genzyme Corporation (acquired by Sanofi in 2011). She has also taught as an Adjunct Lecturer in the Master of Science in Regulatory Affairs program at Northeastern University’s College of Professional Studies. She earned her bachelor’s degree in chemistry and biology from Valparaiso University (Valparaiso, Indiana) and her juris doctor from Suffolk University Law School (Boston, Massachusetts).
Positions
- Company NameClimb Bio, Inc.Stock CodeCLYMPositionSenior VP, General Counsel & SecretaryColleagues
- AMAoife M. BrennanCEO, President & Director
- DEDouglas Edward WilliamsIndependent Chairman of the Board
- SASusan AltschullerCFO & Principal Accounting Officer
- PWPerrin WilsonChief Business Officer
- AVAdam VillaSenior Vice President of Technical Operations
- AGAlexander G. CumboIndependent Director
- KCKimberlee Cobleigh DrapkinIndependent Director
- JAJudith A. DunnIndependent Director
